Rhythm Pharmaceuticals, Inc. (RYTM) Financials
RYTM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 442.3 million | 319.4 million |
| Dec. 31, 2025 | 481.2 million | 342.1 million |
| Sept. 30, 2025 | 506.9 million | 358.1 million |
| June 30, 2025 | 372.7 million | 384.6 million |
RYTM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -44.2 million | 23.1 million |
| Dec. 31, 2025 | -26.3 million | 19.3 million |
| Sept. 30, 2025 | -26.6 million | 18.8 million |
| June 30, 2025 | -23.3 million | 15.9 million |
RYTM Net Income
No data available :(
RYTM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 340.6 million | 213.0 million | 3.2 million |
| Dec. 31, 2025 | 388.9 million | 235.2 million | 3.3 million |
| Sept. 30, 2025 | 416.1 million | 146.9 million | 3.5 million |
| June 30, 2025 | 291.0 million | 251.5 million | 4.2 million |
RYTM Shares Outstanding
RYTM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 41.7 million | 63.6 million | - |
| Dec. 31, 2025 | 953000 | 42.0 million | 57.5 million | - |
| Sept. 30, 2025 | - | 46.0 million | 52.4 million | - |
| June 30, 2025 | - | 42.3 million | 45.9 million | - |
RYTM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 60.1 million | 7.2 million |
| Dec. 31, 2025 | 57.3 million | 4.8 million |
| Sept. 30, 2025 | 51.3 million | 5.5 million |
| June 30, 2025 | 48.5 million | 5.5 million |
RYTM Revenue by Segment
Graph available only for paid members. Upgrade to see it.
RYTM
Price: $90.63
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.13 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 483700
Ebitda: -8.2 millionMarket Capitalization: 5.9 billion